Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus
about
Dysregulation of antiviral helicase pathways in systemic lupus erythematosusSystemic lupus erythematosus: strategies to improve pregnancy outcomesBreakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic CellsInterferon-alpha, immune activation and immune dysfunction in treated HIV infectionThe plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functionsTargeting dendritic cell function during systemic autoimmunity to restore toleranceContribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosusPrimary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort.MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.Type I interferon in the pathogenesis of lupus.Effects of pristane alone or combined with chloroquine on macrophage activation, oxidative stress, and TH1/TH2 skewness.Targeting of type I interferon in systemic autoimmune diseasesToll-like receptors in systemic lupus erythematosus: potential for personalized treatment.Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for interventionType I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus.B-cell selection and the development of autoantibodies.Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block.Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9.Recurrent Kikuchi's Disease Treated by Hydroxychloroquine.Clinical and Immunologic Profiles in Incomplete Lupus Erythematosus and Improvement with Hydroxychloroquine Treatment.SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome.Type I IFN signature in primary Sjögren's syndrome patients.Advances in understanding the role of type I interferons in systemic lupus erythematosus.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.Antiphospholipid syndrome: an update.Why are kids with lupus at an increased risk of cardiovascular disease?TSG-6 Downregulates IFN-Alpha and TNF-Alpha Expression by Suppressing IRF7 Phosphorylation in Human Plasmacytoid Dendritic Cells.Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.Update on cardiovascular disease in lupus.Systemic lupus erythematosus: still a challenge for physicians.Immunomodulators in SLE: Clinical evidence and immunologic actions.Ro52 autoantibodies arise from self-reactive progenitors in a mother of a child with neonatal lupus.Treatment of preeclampsia with hydroxychloroquine: a review.Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin.H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study.The effect of hydroxychloroquine on lupus erythematosus-like skin lesions in MRL/lpr mice.Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosusQuinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus.
P2860
Q21129494-ACA69774-F4E5-4FD6-A530-807FAE531D24Q26741149-3673CE2B-434E-4B5D-9473-49372CF0B3EDQ26748941-89ACD040-C778-485D-9ED3-22603FDD4BEEQ26861003-CAB66CB6-B7AC-46E4-88A2-094E1304A40EQ27023380-50518A49-A555-4D69-9C92-15B5225B2F09Q27687098-28D22350-26F8-405E-8430-6C7B888C6E00Q28080920-5C1494C4-CAE6-4A5F-BB40-1E57EC6CD5F1Q30778909-8117DDF3-3378-4E3A-AE55-F99594F60A1DQ33659118-BC4F334A-1F8C-4993-A8DD-D36BE9019083Q33852174-90E401AD-1C28-402D-ABBB-E4EA9FA94564Q34022374-764A302A-A280-41B4-B07E-5DF97884DBE6Q34451758-7CA28CD6-EA1F-46D1-8322-0941E3A31AA9Q34650870-98006C2A-1A92-46BE-8638-65D4444647A1Q35998510-A2DDA3F1-2DB2-4B73-872B-B61A52407D5AQ36042432-D11F043C-0E42-4577-BE4E-0D0959A66F03Q36126483-7B130FBC-1DC8-40D6-917A-74759F06515FQ36504635-A9BF8A2E-7BE9-4783-AD25-E28E6F5E4DA3Q36577968-FFF30E6B-5B15-4B33-B49E-17CBEAACF767Q36740874-160B21A3-3540-4DA6-AC3F-5B7B77629C61Q37096197-9215AD20-DDBA-4E5A-97ED-1CD93E84540AQ37578537-598E1035-7CC4-4E96-BF1E-3487AAC771E0Q37587370-C0A9DA45-D376-4CC7-881D-FA035F6485B9Q38180717-0F0D873A-F360-4691-9980-FF1B91E20F25Q38227972-34D2D3EA-F2BC-43A9-AF90-188A8AC35477Q38335622-3D729481-33B0-433C-81E1-1EA79E8A30EBQ38410376-2C5EBD35-3BAC-47FF-A447-0149B39D18A6Q38591752-A514BBFE-9EB6-4BF2-B3E0-332C35A70465Q38709337-E753FC60-B44E-4650-BDC5-B56F4A292FC0Q38806513-83B5B4F5-B454-4DEF-BDD9-7EEA7F7499B7Q38844782-96B84F1E-CC8B-40E0-8A76-137336DDDE75Q38866356-C358786B-D3AD-4719-B624-7C355C5B07C5Q38883883-DAE5F4ED-3D03-4DD5-B0D7-747CD93352EEQ39001406-E189220D-E397-448D-AE2B-004BFCB5C7C7Q39112090-EB602913-AB3F-4D52-9880-124419A73025Q41476422-E7A18EE6-340E-4212-AC09-7938F6CCBA2AQ41912227-E304B2AE-4379-4FF3-A576-E73A222C5254Q41912597-2E2FDF23-0B50-4706-A810-F484A9DE1335Q41915761-510C9F96-216D-4446-9395-6199AADF7FCEQ42668884-C2E90109-CB72-4F90-8BBE-00CC75D3C396Q47760514-0BA71362-C193-47D2-BFE3-32B545BA04CC
P2860
Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hydroxychloroquine is associat ...... n systemic lupus erythematosus
@ast
Hydroxychloroquine is associat ...... n systemic lupus erythematosus
@en
type
label
Hydroxychloroquine is associat ...... n systemic lupus erythematosus
@ast
Hydroxychloroquine is associat ...... n systemic lupus erythematosus
@en
prefLabel
Hydroxychloroquine is associat ...... n systemic lupus erythematosus
@ast
Hydroxychloroquine is associat ...... n systemic lupus erythematosus
@en
P2093
P2860
P356
P1476
Hydroxychloroquine is associat ...... n systemic lupus erythematosus
@en
P2093
Joseph M McCune
Karim Sacre
Lindsey A Criswell
P2860
P2888
P356
10.1186/AR3895
P577
2012-06-27T00:00:00Z
P5875
P6179
1007441803